This document is an excerpt from the EUR-Lex website
Document 62009CN0156
Case C-156/09: Reference for a preliminary ruling from the Bundesfinanzhof (Germany) lodged on 6 May 2009 — Finanzamt Leverkusen v Verigen Transplantation Service International AG
Case C-156/09: Reference for a preliminary ruling from the Bundesfinanzhof (Germany) lodged on 6 May 2009 — Finanzamt Leverkusen v Verigen Transplantation Service International AG
Case C-156/09: Reference for a preliminary ruling from the Bundesfinanzhof (Germany) lodged on 6 May 2009 — Finanzamt Leverkusen v Verigen Transplantation Service International AG
OJ C 180, 1.8.2009, p. 25–25
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
1.8.2009 |
EN |
Official Journal of the European Union |
C 180/25 |
Reference for a preliminary ruling from the Bundesfinanzhof (Germany) lodged on 6 May 2009 — Finanzamt Leverkusen v Verigen Transplantation Service International AG
(Case C-156/09)
2009/C 180/43
Language of the case: German
Referring court
Bundesfinanzhof
Parties to the main proceedings
Appellant: Finanzamt Leverkusen
Respondent: Verigen Transplantation Service International AG
Questions referred
1. |
Is the first paragraph of Article 28bF of Sixth Council Directive 77/388/EEC of 17 May 1977 (1) on the harmonisation of the laws of the Member States relating to turnover taxes to be interpreted as meaning that:
|
2. |
If any of the above questions is answered in the negative: Is Article 13A(1)(c) of Sixth Council Directive 77/388/EEC of 17 May 1977 on the harmonisation of the laws of the Member States relating to turnover taxes to be interpreted as meaning that the removal of the joint cartilage cells from the cartilage material taken from a human being and the subsequent cell multiplication constitute the ‘provision of medical care’ where the cells obtained from the cell multiplication are reimplanted in the donor? |